Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Development and clinical trials of Z100

Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan
Development and clinical trials of Z100 ( Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan )
3 Jun 2013

Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer

Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )
2 Jun 2013

Extended use of tamoxifen reduces breast cancer recurrence and death

Prof Richard Gray - University of Oxford, Oxford, United Kingdom
Extended use of tamoxifen reduces breast cancer recurrence and death ( Prof Richard Gray - University of Oxford, Oxford, United Kingdom )
2 Jun 2013

Ipilimumab and BRAF inhibitors for advanced melanoma

Dr Lynn Schuchter - University of Pennsylvania, USA
Ipilimumab and BRAF inhibitors for advanced melanoma ( Dr Lynn Schuchter - University of Pennsylvania, USA )
2 Jun 2013

Effect of metformin on cancer risk and mortality

Dr Sara Gandini - European Institute of Oncology (IEO), Milan, Italy
Effect of metformin on cancer risk and mortality ( Dr Sara Gandini - European Institute of Oncology (IEO), Milan, Italy )
2 Jun 2013

PDL1 inhibitors in melanoma

Dr Roy Herbst - Yale Cancer Center, New Haven, USA
PDL1 inhibitors in melanoma ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
2 Jun 2013

Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death

Dr Richard G. Gray - University of Oxford, UK
Ten years of tamoxifen superior to five in reducing breast cancer recurrence and death ( Dr Richard G. Gray - University of Oxford, UK )
2 Jun 2013

Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer

Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA )
2 Jun 2013

No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma

Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA
No survival benefit to adding bevacizumab to standard first-line chemoradiation for glioblastoma ( Dr Mark R. Gilbert - University of Texas MD Anderson Cancer Center, Houston, USA )
2 Jun 2013

Bevacizumab extends survival for relapsed and advanced cervical cancer

Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA
Bevacizumab extends survival for relapsed and advanced cervical cancer ( Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA )
2 Jun 2013

Biennial cervical cancer screening with vinegar reduces mortality

Dr Surendra Srinivas Shastri - Tata Memorial Hospital Mumbai, India
Biennial cervical cancer screening with vinegar reduces mortality ( Dr Surendra Srinivas Shastri - Tata Memorial Hospital Mumbai, India )
2 Jun 2013

Comment on drug developments in advanced melanoma

Dr Roy Herbst - Yale Cancer Center, New Haven, USA
Comment on drug developments in advanced melanoma ( Dr Roy Herbst - Yale Cancer Center, New Haven, USA )
2 Jun 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation